EFC
NYSE Ellington Financial Inc.$12.20 ↑ +0.00 (+0.00%) Trading Up from the previous close of $12.20, $0.20 below the day’s high of $12.40
- YTD change
- -10.16%
- vs 20-day SMA
- -5.59%
- vs 200-day SMA
- -7.18%
Price ranges
Price & Performance
+0.44 (+3.74%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 37.8% away from all-time highs of $19.60
- EFC is down 10% since the beginning of the year
- EFC is down 7% over the past 12 months
- EFC is down 10% over the past 1 month
- 6% of all EFC investors are betting against EFC
- Number of investors short EFC has gone up 11% versus last month
EFC reads poor: price sits below both the 20- and 200-day averages, short interest is rising month over month, the 12-month move is -6.2%.
- Previous minute
- -$0.01
- Last hour
- +$0.05
- Last 5 days
- -1.93%
- vs 8-day SMA
- -2.49%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Ellington Financial, Inc. engages in the provision of investment services. It operates through the Investment Portfolio and Longbridge segments. The Investment Portfolio segment is focused on investing in a diverse array of financial assets, which includes residential and commercial mortgage loans, reverse mortgage loans, residential mortgage-backed securities, commercial mortgage-backed securities, consumer loans & asset-backed securities backed, collateralized loan obligations, non-mortgage and mortgage-related derivatives, debt and equity investments in loan origination companies. The Longbridge segment consists of the origination and servicing of reverse mortgage loans. The company was founded on July 9, 2007 and is headquartered in Old Greenwich, CT.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.